Market revenue in 2022 | USD 3,578.8 million |
Market revenue in 2030 | USD 5,071.6 million |
Growth rate | 4.5% (CAGR from 2022 to 2030) |
Largest segment | Dietary supplements |
Fastest growing segment | Dietary Supplements |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | OTC pharma products, Dietary Supplements |
Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
Dietary supplements was the largest segment with a revenue share of 94.32% in 2024. Horizon Databook has segmented the Europe menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
The region has a large number of women entering menopause every year, along with a high prevalence of menopausal symptoms such as vaginal dryness. Key players are introducing new products in the market, and medical practitioners are recommending dietary supplements as a healthy alternative to HRT for easing transition through menopause.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account